CTGov Compliance My Organizations

Compliance Rate

Compliance Rate 47.32%

Compliant submissions 53

Incompliant submissions 59

Total trials 112

My Organizations' Clinical Trials

Showing 225 of 1129 entries

View as:

Motivating Smokers--Reduce Child Environmental Tobacco Smoke Exposure

Phase: N/A Priority: Normal

NCT ID: NCT00005396 Org: User:

Start: 09/30/94 End: 08/31/99 Due: 08/31/00

Peer-Based Skills Training to Enhance Teen Weight Loss

Phase: N/A Priority: Normal

NCT ID: NCT00024830 Org: User:

Start: 09/30/99 End: 08/31/02 Due: 08/31/03

TB Contact Investigation: Behavioral Intervention

Phase: N/A Priority: Normal

NCT ID: NCT00005740 Org: User:

Start: 09/30/95 End: 08/31/00 Due: 08/31/01

Bioprosthetic or Native Aortic Scallop Intentional Laceration to Prevent Iatrogenic Coronary Artery Obstruction (BASILICA) Prospective Investigation

Phase: N/A Priority: Normal

NCT ID: NCT03381989 Org: User:

Start: 02/14/18 End: 08/22/19 Due: 08/22/20

Physiological and Psychosocial Correlates of Type A Behavior

Phase: N/A Priority: Normal

NCT ID: NCT00005155 Org: User:

Start: 02/28/82 End: 01/31/89 Due: 01/31/90

Randomized Trial of Imaging Versus Risk Factor-Based Therapy for Plaque Regression

Phase: N/A Priority: Normal

NCT ID: NCT01212900 Org: User:

Start: 09/30/10 End: 02/22/17 Due: 02/22/18

Evaluating How the Treatments in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Study Affect Diabetic Retinopathy (The ACCORD Eye Study)

Phase: N/A Priority: Normal

NCT ID: NCT00542178 Org: User:

Start: 10/31/03 End: 12/31/09 Due: 12/31/10

Sildenafil to Increase Exercise Capacity in Individuals With Idiopathic Pulmonary Fibrosis and Pulmonary Hypertension

Phase: N/A Priority: Normal

NCT ID: NCT00352482 Org: User:

Start: 11/30/04 End: 07/31/07 Due: 07/31/08

Postprandial Lipemia and Endothelial Function in ACCORD- Ancillary to ACCORD

Phase: N/A Priority: Normal

NCT ID: NCT00037401 Org: User:

Start: 09/30/01 End: 08/31/05 Due: 08/31/06

Regulation of Placental Vascular Reactivity in Pregnancy-induced Hypertension

Phase: N/A Priority: Normal

NCT ID: NCT00005208 Org: User:

Start: 09/30/87 End: 07/31/92 Due: 07/31/93

Epcoritamab in Chronic Lymphocytic Leukemia and Richter Syndrome

Phase: N/A Priority: Normal

NCT ID: NCT06676033 Org: User:

Start: 07/02/25 End: 07/01/27 Due: 07/01/28

Genes Involved in Lipid Disorders

Phase: N/A Priority: Normal

NCT ID: NCT02311335 Org: User:

Start: 11/26/14 End: 09/02/21 Due: 09/02/22

Extension Study (Extended Access) of Syk-inhibition Using Fostamatinib to Treat Posttransplant Immune-mediated Cytopenias

Phase: N/A Priority: Normal

NCT ID: NCT05509582 Org: User:

Start: 07/02/25 End: 12/01/28 Due: 12/01/29

Long-term Evaluation and Follow-up Care of Patients Treated With Stem Cell Transplants

Phase: N/A Priority: Normal

NCT ID: NCT00106925 Org: User:

Start: 04/22/05 End: - Due: -

Identification of an Asthma Susceptibility Gene on 3P

Phase: N/A Priority: Normal

NCT ID: NCT00006510 Org: User:

Start: 09/30/00 End: 08/31/06 Due: 08/31/07

Hydroxyurea to Prevent Organ Damage in Children With Sickle Cell Anemia

Phase: N/A Priority: Normal

NCT ID: NCT00006400 Org: User:

Start: 08/31/00 End: 09/30/09 Due: 09/30/10

Sildenafil Therapy for Pulmonary Hypertension and Sickle Cell Disease

Phase: N/A Priority: Normal

NCT ID: NCT00492531 Org: User:

Start: 06/30/07 End: 10/31/09 Due: 10/31/10

International Programs Collaborative Studies Coordinating Center

Phase: N/A Priority: Normal

NCT ID: NCT00005312 Org: User:

Start: 01/31/90 End: 08/31/02 Due: 08/31/03

Patient-Physician Partnership to Improve High Blood Pressure Adherence

Phase: N/A Priority: Normal

NCT ID: NCT00123045 Org: User:

Start: 09/30/01 End: 08/31/05 Due: 08/31/06

Worcester Heart Attack Community Surveillance Study

Phase: N/A Priority: Normal

NCT ID: NCT00005196 Org: User:

Start: 12/31/86 End: 03/31/06 Due: 03/31/07

Congestive Heart Failure Trends in the Elderly 1970-94

Phase: N/A Priority: Normal

NCT ID: NCT00005499 Org: User:

Start: 07/31/98 End: 06/30/01 Due: 06/30/02

Stepped Intervention for Meds Adherence and Blood Pressure Control

Phase: N/A Priority: Normal

NCT ID: NCT00257101 Org: User:

Start: 09/30/01 End: 08/31/06 Due: 08/31/07

Vaccine Responses in Patients With B Cell Malignancies

Phase: N/A Priority: Normal

NCT ID: NCT05170399 Org: User:

Start: 09/14/22 End: 08/16/25 Due: 08/16/26

Cardiac Function in Patients With Hereditary Hemochromatosis

Phase: N/A Priority: Normal

NCT ID: NCT00068159 Org: User:

Start: 12/08/03 End: 07/06/22 Due: 07/06/23

Decline in Cardiovascular Mortality: Framingham 1950-1984

Phase: N/A Priority: Normal

NCT ID: NCT00005222 Org: User:

Start: 04/30/88 End: 03/31/96 Due: 03/31/97

Title	NCT ID	Organization	User	Status	Start Date	End Date	Reporting Due Date	Last Checked	User Role	Org Created
Motivating Smokers--Reduce Child Environmental Tobacco Smoke Exposure	NCT00005396	National Heart, Lung, and Blood Institute (NHLBI)	user2@example.com	None	1994-09-30	1999-08-31	2000-08-31	-	-	2025-07-14
Peer-Based Skills Training to Enhance Teen Weight Loss	NCT00024830	National Heart, Lung, and Blood Institute (NHLBI)	user2@example.com	None	1999-09-30	2002-08-31	2003-08-31	-	-	2025-07-14
TB Contact Investigation: Behavioral Intervention	NCT00005740	National Heart, Lung, and Blood Institute (NHLBI)	user2@example.com	None	1995-09-30	2000-08-31	2001-08-31	-	-	2025-07-14
Bioprosthetic or Native Aortic Scallop Intentional Laceration to Prevent Iatrogenic Coronary Artery Obstruction (BASILICA) Prospective Investigation	NCT03381989	National Heart, Lung, and Blood Institute (NHLBI)	user2@example.com	None	2018-02-14	2019-08-22	2020-08-22	-	-	2025-07-14
Physiological and Psychosocial Correlates of Type A Behavior	NCT00005155	National Heart, Lung, and Blood Institute (NHLBI)	user2@example.com	None	1982-02-28	1989-01-31	1990-01-31	-	-	2025-07-14
Randomized Trial of Imaging Versus Risk Factor-Based Therapy for Plaque Regression	NCT01212900	National Heart, Lung, and Blood Institute (NHLBI)	user2@example.com	None	2010-09-30	2017-02-22	2018-02-22	-	-	2025-07-14
Evaluating How the Treatments in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Study Affect Diabetic Retinopathy (The ACCORD Eye Study)	NCT00542178	National Heart, Lung, and Blood Institute (NHLBI)	user2@example.com	None	2003-10-31	2009-12-31	2010-12-31	-	-	2025-07-14
Sildenafil to Increase Exercise Capacity in Individuals With Idiopathic Pulmonary Fibrosis and Pulmonary Hypertension	NCT00352482	National Heart, Lung, and Blood Institute (NHLBI)	user2@example.com	None	2004-11-30	2007-07-31	2008-07-31	-	-	2025-07-14
Postprandial Lipemia and Endothelial Function in ACCORD- Ancillary to ACCORD	NCT00037401	National Heart, Lung, and Blood Institute (NHLBI)	user2@example.com	None	2001-09-30	2005-08-31	2006-08-31	-	-	2025-07-14
Regulation of Placental Vascular Reactivity in Pregnancy-induced Hypertension	NCT00005208	National Heart, Lung, and Blood Institute (NHLBI)	user2@example.com	None	1987-09-30	1992-07-31	1993-07-31	-	-	2025-07-14
Epcoritamab in Chronic Lymphocytic Leukemia and Richter Syndrome	NCT06676033	National Heart, Lung, and Blood Institute (NHLBI)	user2@example.com	None	2025-07-02	2027-07-01	2028-07-01	-	-	2025-07-14
Genes Involved in Lipid Disorders	NCT02311335	National Heart, Lung, and Blood Institute (NHLBI)	user2@example.com	None	2014-11-26	2021-09-02	2022-09-02	-	-	2025-07-14
Extension Study (Extended Access) of Syk-inhibition Using Fostamatinib to Treat Posttransplant Immune-mediated Cytopenias	NCT05509582	National Heart, Lung, and Blood Institute (NHLBI)	user2@example.com	None	2025-07-02	2028-12-01	2029-12-01	-	-	2025-07-14
Long-term Evaluation and Follow-up Care of Patients Treated With Stem Cell Transplants	NCT00106925	National Heart, Lung, and Blood Institute (NHLBI)	user2@example.com	None	2005-04-22	-	-	-	-	2025-07-14
Identification of an Asthma Susceptibility Gene on 3P	NCT00006510	National Heart, Lung, and Blood Institute (NHLBI)	user2@example.com	None	2000-09-30	2006-08-31	2007-08-31	-	-	2025-07-14
Hydroxyurea to Prevent Organ Damage in Children With Sickle Cell Anemia	NCT00006400	National Heart, Lung, and Blood Institute (NHLBI)	user2@example.com	None	2000-08-31	2009-09-30	2010-09-30	-	-	2025-07-14
Sildenafil Therapy for Pulmonary Hypertension and Sickle Cell Disease	NCT00492531	National Heart, Lung, and Blood Institute (NHLBI)	user2@example.com	None	2007-06-30	2009-10-31	2010-10-31	-	-	2025-07-14
International Programs Collaborative Studies Coordinating Center	NCT00005312	National Heart, Lung, and Blood Institute (NHLBI)	user2@example.com	None	1990-01-31	2002-08-31	2003-08-31	-	-	2025-07-14
Patient-Physician Partnership to Improve High Blood Pressure Adherence	NCT00123045	National Heart, Lung, and Blood Institute (NHLBI)	user2@example.com	None	2001-09-30	2005-08-31	2006-08-31	-	-	2025-07-14
Worcester Heart Attack Community Surveillance Study	NCT00005196	National Heart, Lung, and Blood Institute (NHLBI)	user2@example.com	None	1986-12-31	2006-03-31	2007-03-31	-	-	2025-07-14
Congestive Heart Failure Trends in the Elderly 1970-94	NCT00005499	National Heart, Lung, and Blood Institute (NHLBI)	user2@example.com	None	1998-07-31	2001-06-30	2002-06-30	-	-	2025-07-14
Stepped Intervention for Meds Adherence and Blood Pressure Control	NCT00257101	National Heart, Lung, and Blood Institute (NHLBI)	user2@example.com	None	2001-09-30	2006-08-31	2007-08-31	-	-	2025-07-14
Vaccine Responses in Patients With B Cell Malignancies	NCT05170399	National Heart, Lung, and Blood Institute (NHLBI)	user2@example.com	None	2022-09-14	2025-08-16	2026-08-16	-	-	2025-07-14
Cardiac Function in Patients With Hereditary Hemochromatosis	NCT00068159	National Heart, Lung, and Blood Institute (NHLBI)	user2@example.com	None	2003-12-08	2022-07-06	2023-07-06	-	-	2025-07-14
Decline in Cardiovascular Mortality: Framingham 1950-1984	NCT00005222	National Heart, Lung, and Blood Institute (NHLBI)	user2@example.com	None	1988-04-30	1996-03-31	1997-03-31	-	-	2025-07-14

Compliance Rate

My Organizations' Clinical Trials

Appearance